drugset / Trial / NCT03098940

A Bioavailability Study on Dronabinol

NCT03098940

Phase 1 Unknown 50 enrolled Axim Biotechnologies
RandomizedCrossoverOpen-labelTreatment

Summary

This study is a two part study

Timeline

Start
2018-01
Primary completion
2018-04
Completion
2018-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Dronabinol Other / unclassified

Indications